Perceval Sutureless Implant Versus Standard-Aortic Valve Replacement
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 914 participants.
Also called NCT02673697
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 914 participants
- Sponsor
- Corcym S.r.l
- Registry
-
NCT02673697
-
- Other papers using this trial's data
- Pacemaker implantation after sutureless or stented valve: results from a controlled randomized trial
- Perioperative platelet reduction after sutureless or stented valve implantation: results from the PERSIST-AVR controlled randomized trial
- Sutureless versus conventional bioprostheses for aortic valve replacement in severe symptomatic aortic valve stenosis
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Austria, Belgium, Canada, Chile, France, Germany, Israel, Italy, Netherlands, Spain, United Kingdom
- Registry status
- Terminated
Technical summary
Registry record NCT02673697. Randomized; no masking; primary purpose treatment. Start 2016-03-22 (actual); primary completion 2020-01-17 (actual). Results posted on 2022-07-27.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Perceval Sutureless Implant Versus Standard-Aortic Valve Replacement
- Acronym
- PERSIST-AVR
- Condition
- Aortic Valve Disease
- Condition
- Aortic Stenosis
- Intervention (Device)
- Perceval valve
- Intervention (Device)
- other stented biological valve
- Lead sponsor
- Corcym S.r.l
Record details
- Record id
cardio:ct-nct02673697- Content hash
c3ba89ec58c89080d7195983cc61cc7fb0fbc5c8b2285cbacc773d07535b3b24